132 related articles for article (PubMed ID: 15584974)
1. Reduction of soluble complement receptor 2/CD21 in systemic lupus erythomatosus and Sjogren's syndrome but not juvenile arthritis.
Masilamani M; Nowack R; Witte T; Schlesier M; Warnatz K; Glocker MO; Peter HH; Illges H
Scand J Immunol; 2004 Dec; 60(6):625-30. PubMed ID: 15584974
[TBL] [Abstract][Full Text] [Related]
2. Decreased levels of serum soluble complement receptor-II (CR2/CD21) in patients with rheumatoid arthritis.
Masilamani M; von Kempis J; Illges H
Rheumatology (Oxford); 2004 Feb; 43(2):186-90. PubMed ID: 12867574
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
[TBL] [Abstract][Full Text] [Related]
4. B cell activation leads to shedding of complement receptor type II (CR2/CD21).
Masilamani M; Kassahn D; Mikkat S; Glocker MO; Illges H
Eur J Immunol; 2003 Sep; 33(9):2391-7. PubMed ID: 12938215
[TBL] [Abstract][Full Text] [Related]
5. Systemic reduction of soluble complement receptor II/CD21 during pregnancy to levels reminiscent of autoimmune disease.
Masilamani M; Rajasekaran N; Singh A; Low HZ; Albus K; Anders S; Behne F; Eiermann P; König K; Mindnich C; Ribarska T; Illges H
Rheumatol Int; 2008 Sep; 28(11):1137-41. PubMed ID: 18500464
[TBL] [Abstract][Full Text] [Related]
6. Decreased levels of sCD21 and sCD23 in blood of patients with systemic-juvenile arthritis, polyarticular-juvenile arthritis, and pauciarticular-juvenile arthritis.
Singh A; Vastert SJ; Prakken BJ; Illges H
Rheumatol Int; 2012 Jun; 32(6):1581-7. PubMed ID: 21328056
[TBL] [Abstract][Full Text] [Related]
7. Biosemantics guided gene expression profiling of Sjögren's syndrome: a comparative analysis with systemic lupus erythematosus and rheumatoid arthritis.
Shah NR; Noll BD; Stevens CB; Brennan MT; Mougeot FB; Mougeot JC
Arthritis Res Ther; 2017 Aug; 19(1):192. PubMed ID: 28818099
[TBL] [Abstract][Full Text] [Related]
8. Serum concentrations of cardiac troponin-I in patients with rheumatoid arthritis, systemic lupus erythematosus, primary Sjogren's syndrome and Graves' disease.
Al-Awadhi AM; Olusi S; Hasan EA; Abdullah A
Singapore Med J; 2007 Sep; 48(9):847-9. PubMed ID: 17728967
[TBL] [Abstract][Full Text] [Related]
9. Vasculitis and expression of vascular cell adhesion molecule-1, intercellular adhesion molecule-1, and E-selectin in salivary glands of patients with Sjögren's syndrome.
Turkcapar N; Sak SD; Saatci M; Duman M; Olmez U
J Rheumatol; 2005 Jun; 32(6):1063-70. PubMed ID: 15940769
[TBL] [Abstract][Full Text] [Related]
10. Increased chromogranin A levels indicate sympathetic hyperactivity in patients with rheumatoid arthritis and systemic lupus erythematosus.
Capellino S; Lowin T; Angele P; Falk W; Grifka J; Straub RH
J Rheumatol; 2008 Jan; 35(1):91-9. PubMed ID: 18061980
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
Khan F; Siddiqui AA
Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
[TBL] [Abstract][Full Text] [Related]
12. Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism.
Reefman E; Horst G; Nijk MT; Limburg PC; Kallenberg CG; Bijl M
Arthritis Rheum; 2007 Oct; 56(10):3399-411. PubMed ID: 17907194
[TBL] [Abstract][Full Text] [Related]
13. Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus.
Szanto A; Szodoray P; Kiss E; Kapitany A; Szegedi G; Zeher M
Hum Immunol; 2006 Nov; 67(11):924-30. PubMed ID: 17145372
[TBL] [Abstract][Full Text] [Related]
14. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
Fauchais AL; Boumediene A; Lalloue F; Gondran G; Loustaud-Ratti V; Vidal E; Jauberteau MO
Scand J Rheumatol; 2009; 38(1):50-7. PubMed ID: 18830907
[TBL] [Abstract][Full Text] [Related]
15. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients.
Lin SC; Chen KH; Lin CH; Kuo CC; Ling QD; Chan CH
Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033
[TBL] [Abstract][Full Text] [Related]
16. Soluble CD21 in sera and synovial fluid of arthritic patients.
Grottenthaler T; von Kempis J; Goldacker S; Illges H
Rheumatol Int; 2006 Jan; 26(3):240-3. PubMed ID: 15770483
[TBL] [Abstract][Full Text] [Related]
17. Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3(213-228) in primary Sjogren's syndrome.
Kovács L; Marczinovits I; György A; Tóth GK; Dorgai L; Pál J; Molnár J; Pokorny G
Rheumatology (Oxford); 2005 Aug; 44(8):1021-5. PubMed ID: 15888503
[TBL] [Abstract][Full Text] [Related]
18. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
[TBL] [Abstract][Full Text] [Related]
19. Cortisol during the day in patients with systemic lupus erythematosus or primary Sjogren's syndrome.
van der Goes MC; Bossema ER; Hartkamp A; Godaert GL; Jacobs JW; Kruize AA; Derksen RH; Bijlsma JW; Geenen R
J Rheumatol; 2011 Feb; 38(2):285-8. PubMed ID: 21159832
[TBL] [Abstract][Full Text] [Related]
20. Plasmacytoid dendritic cells and interferon-alpha in Aicardi-Goutières syndrome.
van Heteren JT; van der Knaap MS; Poll The BW; Kuijpers TW
Neuropediatrics; 2007 Dec; 38(6):269-75. PubMed ID: 18461501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
